1. Home
  2. NRXP vs POCI Comparison

NRXP vs POCI Comparison

Compare NRXP & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • POCI
  • Stock Information
  • Founded
  • NRXP 2015
  • POCI 1982
  • Country
  • NRXP United States
  • POCI United States
  • Employees
  • NRXP N/A
  • POCI N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NRXP Health Care
  • POCI Health Care
  • Exchange
  • NRXP Nasdaq
  • POCI Nasdaq
  • Market Cap
  • NRXP 32.6M
  • POCI 31.0M
  • IPO Year
  • NRXP N/A
  • POCI N/A
  • Fundamental
  • Price
  • NRXP $2.09
  • POCI $4.29
  • Analyst Decision
  • NRXP Strong Buy
  • POCI
  • Analyst Count
  • NRXP 4
  • POCI 0
  • Target Price
  • NRXP $28.25
  • POCI N/A
  • AVG Volume (30 Days)
  • NRXP 124.9K
  • POCI 14.2K
  • Earning Date
  • NRXP 05-13-2025
  • POCI 05-14-2025
  • Dividend Yield
  • NRXP N/A
  • POCI N/A
  • EPS Growth
  • NRXP N/A
  • POCI N/A
  • EPS
  • NRXP N/A
  • POCI N/A
  • Revenue
  • NRXP N/A
  • POCI $18,682,766.00
  • Revenue This Year
  • NRXP N/A
  • POCI N/A
  • Revenue Next Year
  • NRXP N/A
  • POCI N/A
  • P/E Ratio
  • NRXP N/A
  • POCI N/A
  • Revenue Growth
  • NRXP N/A
  • POCI N/A
  • 52 Week Low
  • NRXP $1.10
  • POCI $3.47
  • 52 Week High
  • NRXP $6.01
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.92
  • POCI 53.83
  • Support Level
  • NRXP $1.85
  • POCI $3.81
  • Resistance Level
  • NRXP $2.10
  • POCI $4.28
  • Average True Range (ATR)
  • NRXP 0.16
  • POCI 0.19
  • MACD
  • NRXP 0.04
  • POCI 0.05
  • Stochastic Oscillator
  • NRXP 90.18
  • POCI 74.29

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: